Evidence map›Paper›PMID 31659566›Full record

ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2020

Distribution and relevance of Dientamoeba fragilis and Blastocystis species in gastroenteritis: results from a case-control study.

Maria Dullaert- de Boer, Theo A Schuurs, Marloes Vermeer, Gijs J H M Ruijs, Adri G M van der Zanden, Jan F Weel, Lesla E S Bruijnesteijn van Coppenraet

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Molecular epidemiology and genotype diversity of Dientamoeba fragilis in a Czech hospital-based cohort: higher prevalence in paediatric patients and evidence of mixed G1/G2 infection in a single patient.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  2. Molecular epidemiology of Dientamoeba fragilis coinfections with Blastocystis sp. and Giardia duodenalis in symptomatic patients from Valencia, Spain.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Journal of medical microbiology · 2026
    Review
  7. Article
  8. Evolution and ecology of commensal gut protists: recent advances.Current opinion in genetics & development · 2025
    Review
  9. Article
  10. Observational
  11. Blastocystis hominis; Friend or Foe.Integrative medicine (Encinitas, Calif.) · 2024
    Review
  12. Article
  13. Article
  14. Diabetes and gut microbiome.Frontiers in microbiology · 2024
    Review
  15. Article
  16. Treatment ofNew microbes and new infections · 2023
    Article
  17. Evaluation of the Performance of the NovodiagPathogens (Basel, Switzerland) · 2023
    Article
  18. Circulation and colonisation ofEpidemiology and infection · 2023
    Article
  19. A Cross-Sectional Study on the Occurrence of the Intestinal Protist,International journal of molecular sciences · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Maria Dullaert- de BoerLaboratory for Medical Microbiology and Public Health, Hengelo, The Netherlands. maria682093@hotmail.com.ORCID http://orcid.org/0000-0002-3985-1203
Theo A SchuursCentre for Infectious Diseases Friesland, Izore, Leeuwarden, The Netherlands.
Marloes VermeerZGT Academy, ZGT, Almelo, The Netherlands.
Gijs J H M RuijsLaboratory for Medical Microbiology and Infectious Diseases, Isala, Zwolle, The Netherlands.
Adri G M van der ZandenLaboratory for Medical Microbiology and Public Health, Hengelo, The Netherlands.
Jan F WeelCentre for Infectious Diseases Friesland, Izore, Leeuwarden, The Netherlands.
Lesla E S Bruijnesteijn van CoppenraetLaboratory for Medical Microbiology and Infectious Diseases, Isala, Zwolle, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The actual role of Dientamoeba fragilis and Blastocystis in patients with gastrointestinal symptoms is still under debate. A multicenter case-control study was performed in The Netherlands to elucidate the clinical relevance of molecular diagnostics results in gastroenteritis (GE). Samples from this case-control study were used to perform a detailed analysis on the presence of D. fragilis and Blastocystis in relation to gastrointestinal symptoms. In the present study, a real-time PCR for Blastocystis was performed on 1374 case samples and 1026 control samples from the multicenter gastroenteritis case-control study previously tested for D. fragilis. Prevalence of both micro-organisms was highest in children under 20 years of age and lowest in the oldest age group. A significantly lower overall detection of D. fragilis and Blastocystis was found in cases (both 25.8%) as compared to controls (37.6% and 40.0%, respectively). The difference for D. fragilis was statistically significant for subjects above 20 years of age. For Blastocystis, the difference was statistically significant in all age groups, except in children less than 5 years of age. A negative relation between D. fragilis-positive cases and diarrhea was found in this study population. More GE symptoms were reported in cases without D. fragilis or Blastocystis. In the present study, prevalence of both D. fragilis and Blastocystis is lower in cases with gastroenteritic symptoms than in controls. Besides, in cases with D. fragilis or Blastocystis, no association is shown between any of the GE symptoms. Interestingly, this suggests that the presence of these protozoans may be considered characteristic of a healthy intestinal microbiome.

Indexed as

AdolescentAdultBlastocystisBlastocystis InfectionsCase-Control StudiesChildChild, PreschoolDiarrheaDientamoebaDientamoebiasisFecesFemaleGastroenteritisHumansMaleMiddle AgedBlastocystisCase-controlDiarrheaDientamoeba fragilisGastroenteritisMultiplexed real-time PCR

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.